Survival analysis revealed that the high expression level of RPLP2, RPS16, and MRPS16, upregulated in MA-K, was significantly correlated with the poor prognosis of human DLBCL (Figure 3F). Here, MRPS16 is linked to diffuse large B-cell lymphoma.